ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
AtriCure Inc

AtriCure Inc (ATRC)

22.94
-0.825
(-3.47%)
Closed 24 June 6:00AM
22.36
-0.58
(-2.53%)
After Hours: 8:24AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
22.36
Bid
21.91
Offer
23.74
Volume
1,383,133
22.2305 Day's Range 24.03
18.94 52 Week Range 59.61
Market Cap
Previous Close
23.765
Open
23.85
Last Trade
10
@
22.1
Last Trade Time
Financial Volume
US$ 32,195,426
VWAP
23.2772
Average Volume (3m)
792,943
Shares Outstanding
48,382,325
Dividend Yield
-
PE Ratio
-36.42
Earnings Per Share (EPS)
-0.63
Revenue
399.25M
Net Profit
-30.44M

About AtriCure Inc

AtriCure Inc is a innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft T... AtriCure Inc is a innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Wilmington, Delaware, USA
Founded
1970
AtriCure Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker ATRC. The last closing price for AtriCure was US$23.77. Over the last year, AtriCure shares have traded in a share price range of US$ 18.94 to US$ 59.61.

AtriCure currently has 48,382,325 shares in issue. The market capitalisation of AtriCure is US$1.11 billion. AtriCure has a price to earnings ratio (PE ratio) of -36.42.

AtriCure (ATRC) Options Flow Summary

Overall Flow

Bullish

Net Premium

1M

Calls / Puts

100.00%

Buys / Sells

33.33%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

ATRC Latest News

AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management...

Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
11.627.8109932497620.7424.6418.94168720921.82348615CS
4-0.09-0.40089086859722.4524.6418.9482431322.0718045CS
12-8.03-26.42316551530.3930.3918.9479294323.09509762CS
26-12.84-36.477272727335.239.04518.9470291128.16241905CS
52-26.29-54.039054470748.6559.6118.9455255533.31621543CS
156-52.14-69.986577181274.589.1818.9436405543.34861047CS
260-7.64-25.46666666673089.1818.9435873944.19560577CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ME1OEMelodiol Global Health Ltd
AUD 0.006
(100.00%)
34
K2FK2fly Limited
AUD 0.1825
(82.50%)
2.49M
PRXProdigy Gold NL
AUD 0.003
(50.00%)
100.11k
ARVOCArtemis Resources Limited
AUD 0.003
(50.00%)
1.05M
MTBMount Burgess Mining Nl
AUD 0.0015
(50.00%)
5.38k
BNROBulletin Resources Limited
AUD 0.001
(-66.67%)
100k
FRSOAForrestania Resources Ltd
AUD 0.006
(-57.14%)
26k
GGEOAGrand Gulf Energy Limited
AUD 0.001
(-50.00%)
2.18M
D2OOADuxton Water Limited
AUD 0.021
(-47.50%)
4.5k
CT1Constellation Technologies Limited
AUD 0.002
(-33.33%)
50.02k
REDRed 5 Limited
AUD 0.4175
(3.09%)
135.31M
BGLBellevue Gold Limited
AUD 1.835
(-1.34%)
81.32M
NICNickel Industries Ltd
AUD 0.825
(-3.23%)
62.62M
S32South32 Limited
AUD 3.74
(1.77%)
56.22M
CXOCore Lithium Ltd
AUD 0.0855
(-6.04%)
56.06M

ATRC Discussion

View Posts
mlkrborn mlkrborn 11 years ago
HISTORY
Initial Public Offering



On August 10, 2005, we consummated an initial public offering of 4.6 million shares of our common stock at $12.00 per share, which includes the underwriters exercise of their over-allotment option, on August 9, 2005, to purchase 600,000 shares of our common stock of which 450,000 shares were sold by selling shareholders and 150,000 shares were sold by us. We did not receive any proceeds from the sale of the 450,000 shares of common stock that were sold by selling shareholders. These share amounts reflect a 1-for-3.8 reverse split of our capital stock that was effected on July 27, 2005. Proceeds to us from the offering, after deducting underwriting discounts and commissions but before expenses, were $46.3 million. Expenses are estimated to be approximately $3.25 million.



15
👍️0
mlkrborn mlkrborn 11 years ago
AtriCure receives FDA approval for investigational study to evaluate stroke prevention in atrial fibrillation (ATRC) 14.35 : Co announces the FDA approval to begin enrollment in a clinical study of AtriCure's AtriClip Left Atrial Appendage Exclusion System. The study will evaluate the use of the AtriClip device to prevent stroke in patients with Afib. The feasibility study will enroll Afib patients at seven medical centers across the country. The study will focus on patients with risk factors that place them at significant risk of stroke as well as substantial bleeding risks that contraindicate them for anticoagulation therapy. Research suggests that up to 40% of patients are unable to take oral anticoagulants due to excessive risk of bleeding.
👍️0
dmarkg dmarkg 11 years ago
Hey Wobblenuts and Jackie Scan I want to show you something....

Medical Breakthrough Wound Stasis Technology

ATRC and EPGL could possibly go hand in hand here...
Merry Christmas 2012

Merry Chirstmas 2012, friends.
👍️0
wobblenuts wobblenuts 12 years ago
Any talks involving ATRC and soon to be sub penny wonder EPGL?



Are they hinting at something here?


1)"ATRC fully SEC reporting financials are available at OTCMARKETS for EPGL investors to see as an example of where EPGL management is headed."

2)"EPGL initiating R&D on 4 new medical devices before end of 2012."

3)"Property and equipment, net 0"
👍️0
Penny Roger$ Penny Roger$ 12 years ago
~ Monday! $ATRC ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $ATRC ~ Earnings expected on Monday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=ATRC&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=ATRC&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=ATRC
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=ATRC#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=ATRC+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=ATRC
Finviz: http://finviz.com/quote.ashx?t=ATRC
~ BusyStock: http://busystock.com/i.php?s=ATRC&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=ATRC >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.
👍️0
Penny Roger$ Penny Roger$ 12 years ago
AtriCure, Inc., is a medical device company. The Company develops, manufactures and sells cardiac surgical ablation systems designed to create lesions, or scars, in cardiac, or heart, tissue and devices for the exclusion of the left atrial appendage. The Company has two primary product lines for the ablation of cardiac tissue. Its primary product line, which accounts for a majority of its revenues, is Isolator Synergy bipolar ablation clamp system (Isolator system) and related radiofrequency ablation devices. It also offers a cryoablation product line, which features reusable and disposable cryoablation devices. In addition, it offers the AtriClip Gillinov-Cosgrove Left Atrial Appendage System, or AtriClip system, which is designed to exclude the left atrial appendage.

http://www.google.com/finance?q=ATRC
👍️0